Recordati Industria Chimi...

PNK: RCDTF · Real-Time Price · USD
56.04
0.00 (0.00%)
At close: Apr 24, 2025, 10:47 AM

Company Description

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide.

The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat.

It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates.

The company was founded in 1926 and is headquartered in Milan, Italy.

Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.

Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A. logo
Country IT
IPO Date Dec 17, 2010
Industry Drug Manufacturers - General
Sector Healthcare
Employees 4,495
CEO Dr. Robert Koremans M.D.

Contact Details

Address:
1, Via Matteo Civitali
Milan, Michigan
IT
Website https://www.recordati.com

Stock Details

Ticker Symbol RCDTF
Exchange PNK
Fiscal Year January - December
Reporting Currency USD
CIK Code n/a
CUSIP Number n/a
ISIN Number IT0003828271
Employer ID -
SIC Code n/a

Key Executives

Name Position
Dr. Robert Koremans M.D. Chief Executive Officer & Director
Bibianne Bon Group Chief Legal Officer
Luigi Felice La Corte Group Chief Financial Officer & Executive Director
Alessandra Abate Group Chief People & Culture Officer
Cathrin Petty Executive Director
Eugenia Litz Vice President & Head of Investor Relations
Gabriele Finzi Executive Vice President of Corporate Development, Licensing & Innovation
Giampiero Mazza Executive Director
Giorgio De Palma Executive Director
Laura Conti Group Communications Director

Latest SEC Filings

No SEC filings available.